alexa Nanoparticle Based Delivery of miRNAs to Overcome Drug
ISSN: 2157-7439

Journal of Nanomedicine & Nanotechnology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Research Article

Nanoparticle Based Delivery of miRNAs to Overcome Drug Resistance in Breast Cancer

Yalcin S1* and Gunduz U2

1Department of Molecular Biology and Genetics, Faculty of Science and Art, Ahi Evran University, Kırsehir, Turkey

2Department of Biology, Faculty of Science and Art, Middle East Technical University, Ankara, Turkey

*Corresponding Author:
Serap Yalcin
Department of Molecular Biology and Genetics
Faculty of Science and Art
Ahi Evran University
Kırsehir, Turkey
Tel: 90386 280 42 00
E-mail: [email protected]

Received date: December 05, 2016; Accepted date: December 22, 2016; Published date: December 27, 2016

Citation: Yalcin S, Gunduz U (2016) Nanoparticle Based Delivery of miRNAs to Overcome Drug Resistance in Breast Cancer. J Nanomed Nanotechnol 7:414. doi: 10.4172/2157-7439.1000414

Copyright: © 2016 Yalcin S, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

 

Abstract

Nanoparticle-based targeted drug delivery is a successful strategy to overcome the side effect of chemotherapy. Nanoparticles based drug delivery systems that have been designed to enhance delivery of therapeutics to tumors, are a novel approach. Nanoparticles have reactive surface that can be readily modified with biocompatible coatings and loaded with therapeutic agents (miRNA, siRNA, antibody, anti-cancer drug etc..). MicroRNAs (miRNAs or miRs) are short non-coding RNAs which posttranscriptionally regulate growth, differentiation, apoptosis, motility, and malignant transformation. In addition, some miRNAs have been classified as proto-oncogenes. The levels of changed miRNA expression play significant role in the initiation of many diseases, including cancer, especially tumor progression and metastasis. Further studies, miRNA conjugation to drug carrier systems is used to target to cancer cells. In this review, we focus on miRNA carrier nanoparticles, and summarize novel advances about their use in drug resistance breast cancer therapy.

Keywords

Share This Page

Additional Info

Loading
Loading Please wait..
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords